XENOBIOTICA-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=857881, encodeId=c64385e88102, content=审稿速度:1.0 经验分享：审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 11月为0314的文章编号，年文章数为134篇，则命中率在50%左右 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Fri Feb 28 09:53:01 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857880, encodeId=daee85e880e6, content=审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Fri Feb 28 09:47:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576707, encodeId=df345e6707ab, content=第一次投文章，请教各位大神这个杂志药理类文章收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/21/ba0e92dcafc202adce5aa48376370a9f.jpg, createdBy=8a3e5162096, createdName=笨笨li, createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562497, encodeId=cb1456249e43, content=您好，能问一下费用问题吗？请问该杂志怎么收费的呢？137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, beContent=137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562498, encodeId=9a48562498f9, content=您好，请问该杂志怎么收费的呢？132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, beContent=132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553101, encodeId=f3ac553101f0, content=请问多长时间onlineballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收ballack111 2017-11-10 07:27:00 发表: 杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=ballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=280c2014611, createdName=1e1fa76dm80(暂无匿称), createdTime=Wed Feb 28 00:00:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549707, encodeId=38be549e072c, content=这个杂志要不要收重要肝毒性的文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Mon Dec 04 19:17:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549071, encodeId=bab55490e163, content=审稿速度:1.0 经验分享：杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e2c2017848, createdName=ballack111, createdTime=Fri Nov 10 07:27:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534309, encodeId=542153430953, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常快，不错的杂志，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=125a1712153, createdName=nibasu, createdTime=Thu Mar 16 16:26:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531632, encodeId=fd2553163264, content=请问这个杂志接收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161220/IMG58595292C6EA62994.jpg, createdBy=d3c51998142, createdName=Jessicaxff, createdTime=Mon Jan 09 12:25:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]

2020-02-28 ms9688259418763462

审稿速度:1.0
经验分享：审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。
11月为0314的文章编号，年文章数为134篇，则命中率在50%左右

123 0

[GetPortalCommentsPageByObjectIdResponse(id=857881, encodeId=c64385e88102, content=审稿速度:1.0 经验分享：审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 11月为0314的文章编号，年文章数为134篇，则命中率在50%左右 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Fri Feb 28 09:53:01 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857880, encodeId=daee85e880e6, content=审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Fri Feb 28 09:47:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576707, encodeId=df345e6707ab, content=第一次投文章，请教各位大神这个杂志药理类文章收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/21/ba0e92dcafc202adce5aa48376370a9f.jpg, createdBy=8a3e5162096, createdName=笨笨li, createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562497, encodeId=cb1456249e43, content=您好，能问一下费用问题吗？请问该杂志怎么收费的呢？137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, beContent=137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562498, encodeId=9a48562498f9, content=您好，请问该杂志怎么收费的呢？132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, beContent=132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553101, encodeId=f3ac553101f0, content=请问多长时间onlineballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收ballack111 2017-11-10 07:27:00 发表: 杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=ballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=280c2014611, createdName=1e1fa76dm80(暂无匿称), createdTime=Wed Feb 28 00:00:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549707, encodeId=38be549e072c, content=这个杂志要不要收重要肝毒性的文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Mon Dec 04 19:17:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549071, encodeId=bab55490e163, content=审稿速度:1.0 经验分享：杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e2c2017848, createdName=ballack111, createdTime=Fri Nov 10 07:27:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534309, encodeId=542153430953, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常快，不错的杂志，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=125a1712153, createdName=nibasu, createdTime=Thu Mar 16 16:26:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531632, encodeId=fd2553163264, content=请问这个杂志接收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161220/IMG58595292C6EA62994.jpg, createdBy=d3c51998142, createdName=Jessicaxff, createdTime=Mon Jan 09 12:25:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]

2020-02-28 ms2488033177785606

审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。

123 0

[GetPortalCommentsPageByObjectIdResponse(id=857881, encodeId=c64385e88102, content=审稿速度:1.0 经验分享：审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 11月为0314的文章编号，年文章数为134篇，则命中率在50%左右 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Fri Feb 28 09:53:01 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857880, encodeId=daee85e880e6, content=审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Fri Feb 28 09:47:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576707, encodeId=df345e6707ab, content=第一次投文章，请教各位大神这个杂志药理类文章收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/21/ba0e92dcafc202adce5aa48376370a9f.jpg, createdBy=8a3e5162096, createdName=笨笨li, createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562497, encodeId=cb1456249e43, content=您好，能问一下费用问题吗？请问该杂志怎么收费的呢？137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, beContent=137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562498, encodeId=9a48562498f9, content=您好，请问该杂志怎么收费的呢？132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, beContent=132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553101, encodeId=f3ac553101f0, content=请问多长时间onlineballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收ballack111 2017-11-10 07:27:00 发表: 杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=ballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=280c2014611, createdName=1e1fa76dm80(暂无匿称), createdTime=Wed Feb 28 00:00:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549707, encodeId=38be549e072c, content=这个杂志要不要收重要肝毒性的文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Mon Dec 04 19:17:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549071, encodeId=bab55490e163, content=审稿速度:1.0 经验分享：杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e2c2017848, createdName=ballack111, createdTime=Fri Nov 10 07:27:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534309, encodeId=542153430953, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常快，不错的杂志，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=125a1712153, createdName=nibasu, createdTime=Thu Mar 16 16:26:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531632, encodeId=fd2553163264, content=请问这个杂志接收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161220/IMG58595292C6EA62994.jpg, createdBy=d3c51998142, createdName=Jessicaxff, createdTime=Mon Jan 09 12:25:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]

2019-09-21 笨笨li

第一次投文章，请教各位大神这个杂志药理类文章收不收？

134 0

[GetPortalCommentsPageByObjectIdResponse(id=857881, encodeId=c64385e88102, content=审稿速度:1.0 经验分享：审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 11月为0314的文章编号，年文章数为134篇，则命中率在50%左右 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Fri Feb 28 09:53:01 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857880, encodeId=daee85e880e6, content=审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Fri Feb 28 09:47:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576707, encodeId=df345e6707ab, content=第一次投文章，请教各位大神这个杂志药理类文章收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/21/ba0e92dcafc202adce5aa48376370a9f.jpg, createdBy=8a3e5162096, createdName=笨笨li, createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562497, encodeId=cb1456249e43, content=您好，能问一下费用问题吗？请问该杂志怎么收费的呢？137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, beContent=137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562498, encodeId=9a48562498f9, content=您好，请问该杂志怎么收费的呢？132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, beContent=132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553101, encodeId=f3ac553101f0, content=请问多长时间onlineballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收ballack111 2017-11-10 07:27:00 发表: 杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=ballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=280c2014611, createdName=1e1fa76dm80(暂无匿称), createdTime=Wed Feb 28 00:00:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549707, encodeId=38be549e072c, content=这个杂志要不要收重要肝毒性的文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Mon Dec 04 19:17:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549071, encodeId=bab55490e163, content=审稿速度:1.0 经验分享：杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e2c2017848, createdName=ballack111, createdTime=Fri Nov 10 07:27:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534309, encodeId=542153430953, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常快，不错的杂志，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=125a1712153, createdName=nibasu, createdTime=Thu Mar 16 16:26:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531632, encodeId=fd2553163264, content=请问这个杂志接收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161220/IMG58595292C6EA62994.jpg, createdBy=d3c51998142, createdName=Jessicaxff, createdTime=Mon Jan 09 12:25:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]

2018-10-29 中药一枚

您好，能问一下费用问题吗？请问该杂志怎么收费的呢？137****8180(暂无匿称) 2018-02-28 00:00:00 发表:
请问多长时间online

137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online

168 0

[GetPortalCommentsPageByObjectIdResponse(id=857881, encodeId=c64385e88102, content=审稿速度:1.0 经验分享：审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 11月为0314的文章编号，年文章数为134篇，则命中率在50%左右 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Fri Feb 28 09:53:01 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857880, encodeId=daee85e880e6, content=审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Fri Feb 28 09:47:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576707, encodeId=df345e6707ab, content=第一次投文章，请教各位大神这个杂志药理类文章收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/21/ba0e92dcafc202adce5aa48376370a9f.jpg, createdBy=8a3e5162096, createdName=笨笨li, createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562497, encodeId=cb1456249e43, content=您好，能问一下费用问题吗？请问该杂志怎么收费的呢？137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, beContent=137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562498, encodeId=9a48562498f9, content=您好，请问该杂志怎么收费的呢？132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, beContent=132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553101, encodeId=f3ac553101f0, content=请问多长时间onlineballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收ballack111 2017-11-10 07:27:00 发表: 杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=ballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=280c2014611, createdName=1e1fa76dm80(暂无匿称), createdTime=Wed Feb 28 00:00:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549707, encodeId=38be549e072c, content=这个杂志要不要收重要肝毒性的文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Mon Dec 04 19:17:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549071, encodeId=bab55490e163, content=审稿速度:1.0 经验分享：杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e2c2017848, createdName=ballack111, createdTime=Fri Nov 10 07:27:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534309, encodeId=542153430953, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常快，不错的杂志，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=125a1712153, createdName=nibasu, createdTime=Thu Mar 16 16:26:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531632, encodeId=fd2553163264, content=请问这个杂志接收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161220/IMG58595292C6EA62994.jpg, createdBy=d3c51998142, createdName=Jessicaxff, createdTime=Mon Jan 09 12:25:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]

2018-10-29 中药一枚

您好，请问该杂志怎么收费的呢？132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表:
这个杂志要不要收重要肝毒性的文章啊？

132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？

272 0

[GetPortalCommentsPageByObjectIdResponse(id=857881, encodeId=c64385e88102, content=审稿速度:1.0 经验分享：审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 11月为0314的文章编号，年文章数为134篇，则命中率在50%左右 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Fri Feb 28 09:53:01 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857880, encodeId=daee85e880e6, content=审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Fri Feb 28 09:47:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576707, encodeId=df345e6707ab, content=第一次投文章，请教各位大神这个杂志药理类文章收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/21/ba0e92dcafc202adce5aa48376370a9f.jpg, createdBy=8a3e5162096, createdName=笨笨li, createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562497, encodeId=cb1456249e43, content=您好，能问一下费用问题吗？请问该杂志怎么收费的呢？137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, beContent=137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562498, encodeId=9a48562498f9, content=您好，请问该杂志怎么收费的呢？132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, beContent=132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553101, encodeId=f3ac553101f0, content=请问多长时间onlineballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收ballack111 2017-11-10 07:27:00 发表: 杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=ballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=280c2014611, createdName=1e1fa76dm80(暂无匿称), createdTime=Wed Feb 28 00:00:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549707, encodeId=38be549e072c, content=这个杂志要不要收重要肝毒性的文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Mon Dec 04 19:17:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549071, encodeId=bab55490e163, content=审稿速度:1.0 经验分享：杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e2c2017848, createdName=ballack111, createdTime=Fri Nov 10 07:27:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534309, encodeId=542153430953, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常快，不错的杂志，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=125a1712153, createdName=nibasu, createdTime=Thu Mar 16 16:26:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531632, encodeId=fd2553163264, content=请问这个杂志接收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161220/IMG58595292C6EA62994.jpg, createdBy=d3c51998142, createdName=Jessicaxff, createdTime=Mon Jan 09 12:25:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]

2018-02-28 1e1fa76dm80(暂无匿称)

请问多长时间onlineballack111 2017-11-10 发表::
审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收ballack111 2017-11-10 07:27:00 发表:
杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收

ballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收

244 0

[GetPortalCommentsPageByObjectIdResponse(id=857881, encodeId=c64385e88102, content=审稿速度:1.0 经验分享：审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 11月为0314的文章编号，年文章数为134篇，则命中率在50%左右 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Fri Feb 28 09:53:01 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857880, encodeId=daee85e880e6, content=审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Fri Feb 28 09:47:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576707, encodeId=df345e6707ab, content=第一次投文章，请教各位大神这个杂志药理类文章收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/21/ba0e92dcafc202adce5aa48376370a9f.jpg, createdBy=8a3e5162096, createdName=笨笨li, createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562497, encodeId=cb1456249e43, content=您好，能问一下费用问题吗？请问该杂志怎么收费的呢？137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, beContent=137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562498, encodeId=9a48562498f9, content=您好，请问该杂志怎么收费的呢？132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, beContent=132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553101, encodeId=f3ac553101f0, content=请问多长时间onlineballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收ballack111 2017-11-10 07:27:00 发表: 杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=ballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=280c2014611, createdName=1e1fa76dm80(暂无匿称), createdTime=Wed Feb 28 00:00:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549707, encodeId=38be549e072c, content=这个杂志要不要收重要肝毒性的文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Mon Dec 04 19:17:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549071, encodeId=bab55490e163, content=审稿速度:1.0 经验分享：杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e2c2017848, createdName=ballack111, createdTime=Fri Nov 10 07:27:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534309, encodeId=542153430953, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常快，不错的杂志，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=125a1712153, createdName=nibasu, createdTime=Thu Mar 16 16:26:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531632, encodeId=fd2553163264, content=请问这个杂志接收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161220/IMG58595292C6EA62994.jpg, createdBy=d3c51998142, createdName=Jessicaxff, createdTime=Mon Jan 09 12:25:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]

2017-12-04 120e33fdm49(暂无昵称)

这个杂志要不要收重要肝毒性的文章啊？

351 0

[GetPortalCommentsPageByObjectIdResponse(id=857881, encodeId=c64385e88102, content=审稿速度:1.0 经验分享：审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 11月为0314的文章编号，年文章数为134篇，则命中率在50%左右 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Fri Feb 28 09:53:01 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857880, encodeId=daee85e880e6, content=审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Fri Feb 28 09:47:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576707, encodeId=df345e6707ab, content=第一次投文章，请教各位大神这个杂志药理类文章收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/21/ba0e92dcafc202adce5aa48376370a9f.jpg, createdBy=8a3e5162096, createdName=笨笨li, createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562497, encodeId=cb1456249e43, content=您好，能问一下费用问题吗？请问该杂志怎么收费的呢？137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, beContent=137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562498, encodeId=9a48562498f9, content=您好，请问该杂志怎么收费的呢？132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, beContent=132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553101, encodeId=f3ac553101f0, content=请问多长时间onlineballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收ballack111 2017-11-10 07:27:00 发表: 杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=ballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=280c2014611, createdName=1e1fa76dm80(暂无匿称), createdTime=Wed Feb 28 00:00:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549707, encodeId=38be549e072c, content=这个杂志要不要收重要肝毒性的文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Mon Dec 04 19:17:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549071, encodeId=bab55490e163, content=审稿速度:1.0 经验分享：杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e2c2017848, createdName=ballack111, createdTime=Fri Nov 10 07:27:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534309, encodeId=542153430953, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常快，不错的杂志，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=125a1712153, createdName=nibasu, createdTime=Thu Mar 16 16:26:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531632, encodeId=fd2553163264, content=请问这个杂志接收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161220/IMG58595292C6EA62994.jpg, createdBy=d3c51998142, createdName=Jessicaxff, createdTime=Mon Jan 09 12:25:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]

2017-11-10 ballack111

审稿速度:1.0
经验分享：杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收

304 0

[GetPortalCommentsPageByObjectIdResponse(id=857881, encodeId=c64385e88102, content=审稿速度:1.0 经验分享：审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 11月为0314的文章编号，年文章数为134篇，则命中率在50%左右 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Fri Feb 28 09:53:01 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857880, encodeId=daee85e880e6, content=审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Fri Feb 28 09:47:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576707, encodeId=df345e6707ab, content=第一次投文章，请教各位大神这个杂志药理类文章收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/21/ba0e92dcafc202adce5aa48376370a9f.jpg, createdBy=8a3e5162096, createdName=笨笨li, createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562497, encodeId=cb1456249e43, content=您好，能问一下费用问题吗？请问该杂志怎么收费的呢？137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, beContent=137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562498, encodeId=9a48562498f9, content=您好，请问该杂志怎么收费的呢？132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, beContent=132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553101, encodeId=f3ac553101f0, content=请问多长时间onlineballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收ballack111 2017-11-10 07:27:00 发表: 杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=ballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=280c2014611, createdName=1e1fa76dm80(暂无匿称), createdTime=Wed Feb 28 00:00:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549707, encodeId=38be549e072c, content=这个杂志要不要收重要肝毒性的文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Mon Dec 04 19:17:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549071, encodeId=bab55490e163, content=审稿速度:1.0 经验分享：杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e2c2017848, createdName=ballack111, createdTime=Fri Nov 10 07:27:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534309, encodeId=542153430953, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常快，不错的杂志，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=125a1712153, createdName=nibasu, createdTime=Thu Mar 16 16:26:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531632, encodeId=fd2553163264, content=请问这个杂志接收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161220/IMG58595292C6EA62994.jpg, createdBy=d3c51998142, createdName=Jessicaxff, createdTime=Mon Jan 09 12:25:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]

2017-03-16 nibasu

审稿速度:1.0 | 投稿命中率:50.0
经验分享：非常快，不错的杂志，小修后接收。

176 0

[GetPortalCommentsPageByObjectIdResponse(id=857881, encodeId=c64385e88102, content=审稿速度:1.0 经验分享：审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 11月为0314的文章编号，年文章数为134篇，则命中率在50%左右 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Fri Feb 28 09:53:01 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=857880, encodeId=daee85e880e6, content=审稿速度很快，2015.11.1投稿，2015.11.20悲剧。审稿人意见很中肯，审稿很认真，提出了很多修改意见，包括英文书写和实验设计方面。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd565414133, createdName=ms2488033177785606, createdTime=Fri Feb 28 09:47:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576707, encodeId=df345e6707ab, content=第一次投文章，请教各位大神这个杂志药理类文章收不收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/21/ba0e92dcafc202adce5aa48376370a9f.jpg, createdBy=8a3e5162096, createdName=笨笨li, createdTime=Sat Sep 21 00:00:00 CST 2019, time=2019-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562497, encodeId=cb1456249e43, content=您好，能问一下费用问题吗？请问该杂志怎么收费的呢？137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, beContent=137****8180(暂无匿称) 2018-02-28 00:00:00 发表: 请问多长时间online, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562498, encodeId=9a48562498f9, content=您好，请问该杂志怎么收费的呢？132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, beContent=132lILv4449(暂无昵称) 2017-12-04 19:17:00 发表: 这个杂志要不要收重要肝毒性的文章啊？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=272, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13612472460, createdName=中药一枚, createdTime=Mon Oct 29 00:00:00 CST 2018, time=2018-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553101, encodeId=f3ac553101f0, content=请问多长时间onlineballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收ballack111 2017-11-10 07:27:00 发表: 杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=ballack111 2017-11-10 发表:: 审稿时间:约1个月杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=280c2014611, createdName=1e1fa76dm80(暂无匿称), createdTime=Wed Feb 28 00:00:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549707, encodeId=38be549e072c, content=这个杂志要不要收重要肝毒性的文章啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8202215057, createdName=120e33fdm49(暂无昵称), createdTime=Mon Dec 04 19:17:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549071, encodeId=bab55490e163, content=审稿速度:1.0 经验分享：杂志分数2.0上下.适合发表药物代谢类文章本人9月26日投稿 10月11日一审回复大修后发表评审问题很专业要认真逐条仔细回答 11月8日修回一天后接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e2c2017848, createdName=ballack111, createdTime=Fri Nov 10 07:27:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534309, encodeId=542153430953, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：非常快，不错的杂志，小修后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=125a1712153, createdName=nibasu, createdTime=Thu Mar 16 16:26:00 CST 2017, time=2017-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531632, encodeId=fd2553163264, content=请问这个杂志接收case吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161220/IMG58595292C6EA62994.jpg, createdBy=d3c51998142, createdName=Jessicaxff, createdTime=Mon Jan 09 12:25:00 CST 2017, time=2017-01-09, status=1, ipAttribution=)]

2017-01-09 Jessicaxff

请问这个杂志接收case吗

244 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务